Multicenter comparison of the etest and EUCAST methods for antifungal susceptibility testing of Candida isolates to micafungin

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 5088-5091

  Bougnoux, M E ^a   Dannaoui, E ^a   Accoceberry, I ^b   Angoulvant, A ^c   Bailly, E ^d   Botterel, F ^e   Chevrier, S ^f   Chouaki, T ^g   Cornet, M ^h   Dalle, F ⁱ   Datry, A ^j   Dupuis, A ^a   Fekkar, A ^j,k   Gangneux, J P ^f   Guitard, J ^k,l   Hennequin, C ^k,l   Le Govic, Y ^m   Le Pape, P ⁿ   Maubon, D ^h   Ranque, S ^o   Sautour, M ^j   Sendid, B ^p   Chandenier, J ^d,q   more..

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c BICÊTRE HOSPITAL   (France)

^d UNIVERSITY HOSPITAL OF TOURS   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f RENNES UNIVERSITY HOSPITAL   (France)

^g AMIENS UNIVERSITY HOSPITAL   (France)

^h UNIV GRENOBLE ALPES   (France)

ⁱ DIJON UNIVERSITY HOSPITAL   (France)

^j ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^k SORBONNE UNIVERSITÉ   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m ANGERS UNIVERSITY HOSPITAL   (France)

ⁿ NANTES UNIVERSITY HOSPITAL   (France)

^o Aix Marseilles University   (France)

^p LILLE UNIVERSITY HOSPITAL   (France)

^q UNIVERSITÉ DE TOURS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICAFUNGIN; ANTIFUNGAL AGENT; ECHINOCANDIN; LIPOPEPTIDE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CLAVISPORA LUSITANIAE; CYBERLINDNERA JADINII; DILUTION; EPSILOMETER TEST; EUROPEAN COMMITTEE ON ANTIMICROBIAL SUSCEPTIBILITY TESTING; HUMAN; IN VITRO STUDY; KLUYVEROMYCES MARXIANUS; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NONHUMAN; PICHIA KUDRIAVZEVII; PRIORITY JOURNAL; SPECIES IDENTIFICATION; TORULASPORA DELBRUECKII; ANTIFUNGAL RESISTANCE; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST;

ANTIFUNGAL AGENTS; CANDIDA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS;

EID: 84979619739     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00630-16     Document Type: Article

References (22)

1. Dannaoui E, Lortholary O, Raoux D, Bougnoux ME, Galeazzi G, Lawrence C, Moissenet D, Poilane I, Hoinard D, Dromer F. 2008. Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother 52:778-781. http://dx.doi.org/10.1128/AAC.01140-07.
2. Montagna MT, Lovero G, Coretti C, Martinelli D, De Giglio O, Iatta R, Balbino S, Rosato A, Caggiano G. 2015. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute broth microdilution methods. BMC Microbiol 15:106. http://dx.doi.org/10.1186/s12866-015-0442-4.
3. Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Florl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J. 2014. Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother 58:916-922. http://dx.doi.org/10.1128/AAC.02020-13.
4. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ; ESCMID Fungal Infection Study Group. 2012. ESCMID∗ guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clin Microbiol Infect 18(Suppl 7):19-37. http://dx.doi.org/10.1111/1469-0691.12039.
5. Groll AH, Stergiopoulou T, Roilides E, Walsh TJ. 2005. Micafungin: pharmacology, experimental therapeutics and clinical applications. Expert Opin Investig Drugs 14:489-509. http://dx.doi.org/10.1517/13543784.14.4.489.
6. Arendrup MC, Perlin DS. 2014. Echinocandin resistance: an emerging clinical problem? Curr Opin Infect Dis 27:484-492. http://dx.doi.org/10.1097/QCO.0000000000000111.
7. Dannaoui E, Desnos-Ollivier M, Garcia-Hermoso D, Grenouillet F, Cassaing S, Baixench MT, Bretagne S, Dromer F, Lortholary O. 2012. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Emerg Infect Dis 18:86-90. http://dx.doi.org/10.3201/eid1801.110556.
8. Fekkar A, Dannaoui E, Meyer I, Imbert S, Brossas JY, Uzunov M, Mellon G, Nguyen S, Guiller E, Caumes E, Leblond V, Mazier D, Fievet MH, Datry A. 2014. Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy? Eur J Clin Microbiol Infect Dis 33:1489-1496. http://dx.doi.org/10.1007/s10096-014-2096-9.
9. Fekkar A, Meyer I, Brossas JY, Dannaoui E, Palous M, Uzunov M, Nguyen S, Leblond V, Mazier D, Datry A. 2013. Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin. Antimicrob Agents Chemother 57:2380-2382. http://dx.doi.org/10.1128/AAC.02037-12.
10. Perlin DS. 2014. Echinocandin resistance, susceptibility testing and prophylaxis: implications for patient management. Drugs 74:1573-1585. http://dx.doi.org/10.1007/s40265-014-0286-5.
11. Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Florl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ. 2012. ESCMID∗guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 18(Suppl 7):9-18. http://dx.doi.org/10.1111/1469-0691.12038.
12. Howell S, Hazen KC. 2011. Candida, Cryptococcus, and other yeasts of medical importance, p 1793-1821. In Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW (ed), Manual of clinical microbiology, 10th ed. ASM Press, Washington, DC.
13. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). 2008. EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398-405. http://dx.doi.org/10.1111/j.1469-0691.2007.01935.x.
14. Cuenca-Estrella M, Arendrup MC, Chryssanthou E, Dannaoui E, Lass-Florl C, Sandven P, Velegraki A, Rodriguez-Tudela JL. 2007. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect 13:1018-1022. http://dx.doi.org/10.1111/j.1469-0691.2007.01790.x.
15. Dannaoui E, Paugam A, Develoux M, Chochillon C, Matheron J, Datry A, Bouges-Michel C, Bonnal C, Dromer F, Bretagne S. 2010. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories. Clin Microbiol Infect 16:863-869. http://dx.doi.org/10.1111/j.1469-0691.2009.02997.x.
16. Arendrup MC, Cuenca-Estrella M, Lass-Florl C, Hope WW, European Committee on Antimicrobial Susceptibility Testing - Subcommittee on Antifungal Susceptibility Testing. 2014. EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole. Mycoses 57:377-379. http://dx.doi.org/10.1111/myc.12170.
17. Arendrup MC, Garcia-Effron G, Lass-Florl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS. 2010. Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and IsoSensitest media. Antimicrob Agents Chemother 54:426-439. http://dx.doi.org/10.1128/AAC.01256-09.
18. Axner-Elings M, Botero-Kleiven S, Jensen RH, Arendrup MC. 2011. Echinocandin susceptibility testing of Candida isolates collected during a 1-year period in Sweden. J Clin Microbiol 49:2516-2521. http://dx.doi.org/10.1128/JCM.00201-11.
19. Baixench MT, Aoun N, Desnos-Ollivier M, Garcia-Hermoso D, Bretagne S, Ramires S, Piketty C, Dannaoui E. 2007. Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 59:1076-1083. http://dx.doi.org/10.1093/jac/dkm095.
20. Espinel-Ingroff A, Canton E, Pelaez T, Peman J. 2011. Comparison of micafungin MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27-A3 document) and Etest for Candida spp. isolates. Diagn Microbiol Infect Dis 70:54-59. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.010.
21. Marcos-Zambrano LJ, Escribano P, Rueda C, Zaragoza O, Bouza E, Guinea J. 2013. Comparison between the EUCAST procedure and the Etest for determination of the susceptibility of Candida species isolates to micafungin. Antimicrob Agents Chemother 57:5767-5770. http://dx.doi.org/10.1128/AAC.01032-13.
22. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN. 2010. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol 48:1592-1599. http://dx.doi.org/10.1128/JCM.02445-09.